FDORA Effect? For Accelerated Approval Class Of 2023, Most Confirmatory Trials At Least Underway

Of 11 NMEs and novel biologics, only one – a vaccine for a tropical disease – did not have confirmatory studies underway or completed at the time of accelerated approval. Statutory changes are forcing companies to prioritize confirmatory trials earlier than in the past.